Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
- DOI
- 10.1016/j.xkme.2022.100574
- Published
- 2023-01
- Container
- Kidney Medicine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.xkme.2022.100574,
title = {Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial},
author = {Obbo W. Bredewold and Joe Chan and My Svensson and Annette Bruchfeld and Johan W. de Fijter and Hans Furuland and Josep M. Grinyo and Anders Hartmann and Hallvard Holdaas and Olof Hellberg and Alan Jardine and Lars Mjörnstedt and Karin Skov and Knut T. Smerud and Inga Soveri and Søren S. Sørensen and Anton-Jan van Zonneveld and Bengt Fellström},
year = {2023},
journal = {Kidney Medicine},
doi = {10.1016/j.xkme.2022.100574},
url = {https://doi.org/10.1016/j.xkme.2022.100574}
}RIS
TY - JOUR TI - Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial AU - Obbo W. Bredewold AU - Joe Chan AU - My Svensson AU - Annette Bruchfeld AU - Johan W. de Fijter AU - Hans Furuland AU - Josep M. Grinyo AU - Anders Hartmann AU - Hallvard Holdaas AU - Olof Hellberg AU - Alan Jardine AU - Lars Mjörnstedt AU - Karin Skov AU - Knut T. Smerud AU - Inga Soveri AU - Søren S. Sørensen AU - Anton-Jan van Zonneveld AU - Bengt Fellström PY - 2023 JO - Kidney Medicine DO - 10.1016/j.xkme.2022.100574 UR - https://doi.org/10.1016/j.xkme.2022.100574 ER -
APA
Bredewold, O. W., Chan, J., Svensson, M., Bruchfeld, A., Fijter, J. W. D., Furuland, H., Grinyo, J. M., Hartmann, A., Holdaas, H., Hellberg, O., Jardine, A., Mjörnstedt, L., Skov, K., Smerud, K. T., Soveri, I., Sørensen, S. S., Zonneveld, A. V., & Fellström, B. (2023). Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial. Kidney Medicine. https://doi.org/10.1016/j.xkme.2022.100574
Source records
- crossref · retrieved 2026-09-26T22:39:05.110Z